| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT06789172 A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors |
Primary endpoint(s) modified |
| 2026-06-12 | NCT06789172 A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors |
Enrollment reduced: 166 -> 146 participants |
| 2026-06-12 | NCT06789172 A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors |
Trial arms changed: 9 -> 7 |
| 2026-05-23 | NCT06305754 Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy… |
overall status: "Recruiting" → "Active Not Recruiting" |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-05 | NCT07629999 Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05455359 | Gastrointestinal Dysmotility on Aspiration Risk | Esophageal Motility Disorders | Recruiting |
| NCT07101445 | Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the… | Multiple Myeloma | Recruiting |
| NCT06241183 | Famotidine and Antacids for Treatment of Dyspepsia | Dyspepsia | Recruiting |
| Phase 3 | |||
| NCT06824467 | A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870)… | Ovarian Cancer | Recruiting |
| NCT06305754 | Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy… | Non-small Cell Lung Cancer (NSCLC) | Active, Not Recruiting |
| Phase 2 | |||
| NCT05977998 | A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and… | Gastric Adenocarcinoma | Recruiting |
| NCT06788912 | Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung… | Lung Neoplasm Malignant | Recruiting |
| NCT04488081 | I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients | COVID-19 | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT06207305 | A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal… | Metastatic Appendiceal Adenocarcinoma | Recruiting |
| NCT06481306 | A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell… | Anemia, Sickle Cell | Recruiting |
| NCT05319730 | A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in… | Esophageal Squamous Cell Carcinoma | Recruiting |
| Phase 1 | |||
| NCT06789172 | A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors | Solid Tumours | Recruiting |
| NCT03805932 | Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience… | Hairy Cell Leukemia | Active, Not Recruiting |
| NCT07629999 | Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in… | Healthy Volunteers | Not Yet Recruiting |